Breaking News Instant updates and real-time market news.

SWKS

Skyworks

$98.51

-0.85 (-0.86%)

12:15
11/18/19
11/18
12:15
11/18/19
12:15

Skyworks put volume heavy and directionally bearish

Bearish flow noted in Skyworks with 7,157 puts trading, or 3x expected. Most active are 11/22 weekly 97.5 puts and 11/22 weekly 99 puts, with total volume in those strikes near 4,700 contracts. The Put/Call Ratio is 2.85, while ATM IV is up nearly 3 points on the day. Earnings are expected on February 4th.

  • 20

    Nov

  • 20

    Nov

  • 21

    Nov

  • 22

    Nov

SWKS Skyworks
$98.51

-0.85 (-0.86%)

11/13/19
RAJA
11/13/19
NO CHANGE
Target $110
RAJA
Outperform
Skyworks price target raised to $110 from $90 at Raymond James
Raymond James analyst Chris Caso raised his price target for Skyworks (SWKS) to $110 from $90 and reiterated an Outperform rating following the company's September quarter results, which included upside to both the quarter and guidance. Caso tells investors in a research note that the magnitude of revenue upside was an order of magnitude less as compared to last week's Qorvo (QRVO) report, which he attributes to Skyworks' more conservative management style, and a particularly conservative approach to Huawei shipments. Caso says Skyworks also appears to be taking a more conservative approach to Huawei shipments as compared to others.
11/13/19
RILY
11/13/19
NO CHANGE
Target $115
RILY
Buy
Skyworks price target raised to $115 from $105 at B. Riley FBR
B. Riley FBR analyst Craig Ellis raised his price target for Skyworks Solutions to $115 from $105 saying the company's quarterly execution was solid overall. Following a multiyear negative estimate revision cycle, a "sustained, positive inflection has begun," Ellis tells investors in a post-earnings research note. The analyst keeps a Buy rating on Skyworks.
11/13/19
BNCH
11/13/19
NO CHANGE
Target $110
BNCH
Buy
Skyworks price target raised to $110 from $94 at Benchmark
Benchmark analyst Ruben Roy raised his price target on Skyworks shares to $110 from $94 after the company reported fiscal Q4 results that were "modestly" above expectations and gave Q1 guidance that was above expectations. The company continues to execute well in challenging markets and he sees Skyworks as a primary beneficiary of the 5G handset cycle accelerating in 2020, Roy tells investors. He keeps a Buy rating on Skyworks shares.
11/13/19
11/13/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Skyworks (SWKS) downgraded to Hold from Buy at Canaccord with analyst T. Michael Walkley saying he believes the company is well positioned to grow faster than the broader semi market for the next several years due to smartphone mix among Chinese OEMs requiring integrated Rf solutions, growing IoT opportunities, and the ramping 5G market opportunities. 2. D.R. Horton (DHI) downgraded to Neutral from Buy at Buckingham. 3. Diplomat Pharmacy (DPLO) downgraded to Equal Weight from Overweight at Barclays with analyst Steven Valiquette saying Diplomat's strategic review is ongoing, which could lead to a sale of the entire company, or simultaneous asset sales that could unlock value. 4. Alcoa (AA) downgraded to Underperform from Neutral at BofA/Merrill with analyst Timna Tanners citing limited catalysts and a cautious aluminum view, adding that while the stock price has risen about 16% since reporting Q3, aluminum price was up only about 6% in that time frame. 5. J.M. Smucker (SJM) downgraded to Underperform from Neutral at Credit Suisse with analyst Robert Moskow saying with consensus already below management's FY20 guidance of $8.35-$8.55, it is fair to say that J.M. Smucker is already an out-of-favor stock, but he believes that consensus and the market underestimate the extent to which earnings will need to be revised lower as structural challenges continue to mount. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

IMMU

Immunomedics

$20.38

1.86 (10.04%)

12:45
12/06/19
12/06
12:45
12/06/19
12:45
Options
Immunomedics call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

12:45
12/06/19
12/06
12:45
12/06/19
12:45
General news
Breaking General news story  »

Week of 12/6 Baker-Hughes…

12:45
12/06/19
12/06
12:45
12/06/19
12:45
General news
Breaking General news story  »

Week of 12/6 Baker-Hughes…

12:40
12/06/19
12/06
12:40
12/06/19
12:40
General news
Treasury's $25 B 2-year FRN reopening stopped at 0.245% »

Treasury's $25 B…

12:40
12/06/19
12/06
12:40
12/06/19
12:40
General news
FX Action: USD-JPY »

FX Action: USD-JPY has…

12:30
12/06/19
12/06
12:30
12/06/19
12:30
General news
Treasury's $25 B 2-year FRN reopening stopped at 0.245% »

Treasury's $25 B…

PIR

Pier 1 Imports

$7.70

-0.27 (-3.39%)

12:22
12/06/19
12/06
12:22
12/06/19
12:22
Periodicals
Pier 1 hired Guggenheim amid concerns over debt, Debtwire reports »

Pier 1 Imports has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDLA

Medallia

$29.11

-0.68 (-2.28%)

12:19
12/06/19
12/06
12:19
12/06/19
12:19
Recommendations
Medallia analyst commentary  »

Oppenheimer says would…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Dec

PIR

Pier 1 Imports

$7.92

-0.05 (-0.63%)

12:19
12/06/19
12/06
12:19
12/06/19
12:19
Periodicals
Breaking Periodicals news story on Pier 1 Imports »

Pier 1 hired financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

12:17
12/06/19
12/06
12:17
12/06/19
12:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

12:16
12/06/19
12/06
12:16
12/06/19
12:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BMY

Bristol-Myers

$60.70

1.195 (2.01%)

, XLRN

Acceleron

$48.58

-0.08 (-0.16%)

12:08
12/06/19
12/06
12:08
12/06/19
12:08
Hot Stocks
Bristol-Myers, Acceleron: FDA says Reblozyl will not be reviewed at ODAC meeting »

Bristol-Myers Squibb…

BMY

Bristol-Myers

$60.70

1.195 (2.01%)

XLRN

Acceleron

$48.58

-0.08 (-0.16%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 08

    Dec

  • 09

    Dec

  • 11

    Dec

  • 04

    Apr

MNTA

Momenta

$17.53

0.68 (4.04%)

12:04
12/06/19
12/06
12:04
12/06/19
12:04
Hot Stocks
Momenta granted orphan status for hemolytic anemia treatment »

The FDA granted Momenta…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 16

    Dec

EA

Electronic Arts

$102.74

0.66 (0.65%)

, ATVI

Activision Blizzard

$55.08

0.09 (0.16%)

12:03
12/06/19
12/06
12:03
12/06/19
12:03
Conference/Events
Wedbush digital media analyst to hold an analyst/industry conference call »

Digital Media Analyst…

EA

Electronic Arts

$102.74

0.66 (0.65%)

ATVI

Activision Blizzard

$55.08

0.09 (0.16%)

GME

GameStop

$6.46

0.1 (1.57%)

NTDOY

Nintendo

$0.00

(0.00%)

TTWO

Take-Two

$123.21

-0.69 (-0.56%)

UBSFY

Ubisoft

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

  • 13

    Dec

PRVL

Prevail Therapeutics

$14.02

-0.03 (-0.21%)

12:02
12/06/19
12/06
12:02
12/06/19
12:02
Hot Stocks
Prevail Therapeutics granted orphan status for dementia treatment »

The FDA granted Prevail…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WEI

Weidai

$4.10

-0.35 (-7.87%)

12:00
12/06/19
12/06
12:00
12/06/19
12:00
Hot Stocks
Weidai falls -8.3% »

Weidai is down -8.3%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PD

PagerDuty

$21.79

-3.2 (-12.81%)

12:00
12/06/19
12/06
12:00
12/06/19
12:00
Hot Stocks
PagerDuty falls -12.8% »

PagerDuty is down -12.8%,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

YEXT

Yext

$14.02

-2.595 (-15.62%)

12:00
12/06/19
12/06
12:00
12/06/19
12:00
Hot Stocks
Yext falls -15.4% »

Yext is down -15.4%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CC

Chemours

$17.08

2.02 (13.41%)

12:00
12/06/19
12/06
12:00
12/06/19
12:00
Hot Stocks
Chemours rises 13.4% »

Chemours is up 13.4%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

BIG

Big Lots

$24.21

5.04 (26.29%)

12:00
12/06/19
12/06
12:00
12/06/19
12:00
Hot Stocks
Big Lots rises 26.5% »

Big Lots is up 26.5%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

GCO

Genesco

$49.57

12.63 (34.19%)

12:00
12/06/19
12/06
12:00
12/06/19
12:00
Hot Stocks
Genesco rises 34.1% »

Genesco is up 34.1%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

UBER

Uber

$27.99

-0.655 (-2.29%)

, ALXN

Alexion

$112.31

4.89 (4.55%)

11:58
12/06/19
12/06
11:58
12/06/19
11:58
On The Fly
Fly Intel: Wall Street's top stories at midday »

Stocks have been…

UBER

Uber

$27.99

-0.655 (-2.29%)

ALXN

Alexion

$112.31

4.89 (4.55%)

TTD

Trade Desk

$250.86

10.59 (4.41%)

BIG

Big Lots

$24.19

5.02 (26.19%)

ULTA

Ulta Beauty

$267.17

31.08 (13.16%)

CIEN

Ciena

$34.98

-1.32 (-3.64%)

PD

PagerDuty

$21.81

-3.18 (-12.73%)

YEXT

Yext

$13.99

-2.625 (-15.80%)

ZM

Zoom Video

$62.23

-7.5 (-10.76%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

  • 07

    Dec

  • 12

    Dec

  • 16

    Dec

  • 16

    Dec

  • 12

    Mar

11:58
12/06/19
12/06
11:58
12/06/19
11:58
Conference/Events
Oppenheimer healthcare analysts to hold a KOL dinner meeting »

Analysts hold a Cardiac…

F

Ford

$9.06

0.13 (1.46%)

11:58
12/06/19
12/06
11:58
12/06/19
11:58
Hot Stocks
Ford issues two safety recalls in North America »

Ford Motor Company is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 07

    Jan

  • 04

    Feb

11:57
12/06/19
12/06
11:57
12/06/19
11:57
Conference/Events
William Blair insurance analyst to hold a luncheon meeting »

Insurance Analyst Adam…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.